Dr. R. Mahoney, Neurology
14 miles from site 03
✓ Patient enrolled in 2 CNS trials
Patients for your trial, found.
We find the physicians who have your patients and get them into your trial.
Ask the map
→
Ask the map
→
Why enrollment stalls
Four in five trials miss their enrollment timeline. The patients exist. The physicians who see them are twenty minutes from the site and have never heard of the study.
Ads find strangers. Patients say they would hear about a trial from their own doctor, not a banner. A screener full of strangers is not enrollment.
So we mapped every US physician: what they treat, where they send patients, where those patients live. Then we do the asking, in your name.
Every effective drug had to be tested in someone. Somewhere in the country, that person already exists and already has a doctor. We are building the layer between the two.
How it works
01
Share the trial protocol.
Protocol, site addresses, target enrollment. A PDF is enough. The surfacing agent returns the ranked physicians for each site, with the reason each one is on the list.
02
We find physicians who have your patients.
The outreach agent reaches them by email and phone, in your name. The ask is specific: which of their patients likely qualify and why. Your coordinator joins when a physician is ready.
03
Patients start enrolling.
Patients arrive at the site the way they always have, with a heads-up before each one. A new list every day: who was reached, who replied, who sent patients, which site needs help next.
No PHI leaves the practice. Spellbinder works at the physician level.
HIPAA compliant. Outreach copy MLR approved.
Nothing to install. Exports to your CTMS on request.
What we built
A map of every US physician and two agents that work it. Nobody on your team builds a list, writes an email or chases a reply.
Healthcare Map
Every US physician, resolved from 400+ sources to one profile: what they treat, whom they send patients to, where those patients live, and which trials they have enrolled into before.
Agents
The surfacing agent reads your protocol and sites and delivers a ranked list per site every morning. The outreach agent runs the conversation in your name, follows up, logs every reply and hands the physician to your coordinator when they say yes.
From protocol to enrolled, in order.
10 physicians identified today · 88 miles total
Today
7 visits · 88 miles
Dr. Alex M Vera
Urology · First Visit · Early Adopter
Memorial Sloan Kettering (18 miles)
Strategic first visit — Recent publication creates conversion opportunity
Dr. Richard Lang
Internal Medicine · First Visit · Key Opinion Leader
AHF Healthcare Centers (10 miles)
High-volume KOL with exceptional pharma engagement
Dr. Jane Green
Internal Medicine — Infectious Disease · First Visit · Key Opinion Leader
Midtown Medical Associates (9 miles)
Discovery phase — Establish credibility and assess interest
Dr. Karim Mohammed
Internal Medicine — Infectious Disease · Third Visit · Key Opinion Leader
Bellevue Hospital Center (12 miles)
Follow-up visit — Strong relationship, expand product discussion
What is on the map
Every physician, for any indication.Especially the rare ones.
For every disease, the doctors who treat it and the ones nobody has asked yet.
Type 2 diabetes (GLP-1)
144,800 prescribing
61,900 outside the trial record
Alzheimer's and related dementias
121,800 treating
38,300 outside the trial record
Migraine
91,100 treating
6,500 outside the trial record
Heart failure
55,000 treating
15,500 outside the trial record
Schizophrenia
21,800 treating
2,100 outside the trial record
ATTR amyloidosis
1,900+ treating
190 outside the trial record
Pulmonary arterial hypertension
3,186 treating
252 outside the trial record
Breast cancer
10,300 treating
3,700 outside the trial record
Pulmonary fibrosis
5,815 treating
1,159 outside the trial record
Primary biliary cholangitis
4,800 treating
76,220 share patients
Geographic atrophy
2,800 treating
26,427 share patients
Hereditary angioedema
2,400 treating
7,876 share patients
ALS
1,315 treating
28,593 share patients
Cystic fibrosis
869 treating or researching
11,695 share patients
Spinal muscular atrophy
671 treating
8,026 share patients
Physician counts. Patient volumes are predicted.
83%
of patients identified were interested and referred, because the ask came from their own physician, not an ad.
107 patients identified
One CNS trial, still ramping
Trusted by experts at pharmaceutical companies
“Our coordinators had spent a month finding one physician. Spellbinder gave us three in forty-eight hours. We signed before the contract was drafted.”
One healthcare map for biopharma
The same physician profiles, care patterns and outreach engine serve the clinical team filling a trial and the commercial team preparing a launch.
